Experiences of misuse and symptoms of dependence among people who use gabapentinoids: A qualitative systematic review
Open Access
- 9 October 2024
- journal article
- review article
- Published by Elsevier in International Journal of Drug Policy
- Vol. 133, 104605
Abstract
No abstract availableKeywords
Funding Information
- Australian Government
- National Health and Medical Research Council (2025894)
This publication has 65 references indexed in Scilit:
- Rescheduling gabapentinoids had negligible effects on prescribing behaviour by general practitioners in EnglandPharmacoepidemiology and Drug Safety, 2023
- Trends in the Concurrent Prescription of Opioids and Gabapentin in the US, 2006 to 2018JAMA Internal Medicine, 2023
- Systematic Evaluation of State Policy Interventions Targeting the US Opioid Epidemic, 2007-2018JAMA Network Open, 2021
- Qualitative evidence2019
- A Clinical Overview of Off-label Use of Gabapentinoid DrugsJAMA Internal Medicine, 2019
- Trends in First Gabapentin and Pregabalin Prescriptions in Primary Care in the United Kingdom, 1993-2017JAMA, 2018
- Pregabalin Misuse and Abuse in Jordan: a Qualitative Study of User ExperiencesInternational Journal of Mental Health and Addiction, 2017
- Confronting the Stigma of Opioid Use Disorder—and Its TreatmentJAMA, 2014
- What's in a name? Qualitative description revisitedResearch in Nursing & Health, 2009
- Whatever happened to qualitative description?Research in Nursing & Health, 2000